valrubicin has been researched along with Leukemia, Lymphocytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Israel, M; Potti, G | 1 |
| Kanter, PM; Schwartz, HS | 1 |
2 other study(ies) available for valrubicin and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Adriamycin analogues. Preparation of 9,10-anhydrodaunorubicin, 9,10-anhydroadriamycin, and some related compounds.
Topics: Animals; Antineoplastic Agents; Cell Line; Daunorubicin; Doxorubicin; Humans; Leukemia, Experimental; Leukemia, Lymphoid | 1982 |
DNA damage by anthracycline drugs in human leukemia cells.
Topics: Carubicin; Cells, Cultured; Daunorubicin; DNA Repair; DNA, Neoplasm; Doxorubicin; Drug Evaluation; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Prognosis | 1981 |